[
  {
    "question": "Which cytokine is crucial for eosinophil maturation, recruitment, and survival in allergic asthma?",
    "options": {
      "A": "Interleukin-4",
      "B": "Interleukin-5",
      "C": "Interleukin-13",
      "D": "Tumor Necrosis Factor-alpha"
    },
    "correctAnswer": "B",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "Interleukin-5 (IL-5) is a key Th2 cytokine that plays a central role in eosinophilic inflammation. It promotes the growth, differentiation, activation, and survival of eosinophils, making it a critical target in severe eosinophilic asthma. IL-4 is important for IgE class switching, and IL-13 contributes to mucus hypersecretion and airway remodeling.",
    "highYieldPearl": "IL-5 is the primary cytokine driving eosinophil biology in asthma. Monoclonal antibodies targeting IL-5 (e.g., mepolizumab, reslizumab) or its receptor (e.g., benralizumab) are effective treatments for severe eosinophilic asthma.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Students might confuse IL-5 with IL-4 (IgE production) or IL-13 (mucus/remodeling), all being Th2 cytokines. Understanding the specific roles of each cytokine is key.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_cbnlwh61"
  },
  {
    "question": "The primary mediator responsible for acute bronchoconstriction during the early asthmatic response is?",
    "options": {
      "A": "Leukotriene B4",
      "B": "Prostaglandin D2",
      "C": "Histamine",
      "D": "Bradykinin"
    },
    "correctAnswer": "C",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "Upon allergen re-exposure, mast cells rapidly degranulate, releasing preformed mediators. Histamine, released from mast cells, is a potent bronchoconstrictor and increases vascular permeability, leading to the immediate 'early asthmatic response'. Other mediators like leukotrienes and prostaglandins also contribute but are often more prominent in the late phase or sustained bronchoconstriction.",
    "highYieldPearl": "Histamine's rapid release from mast cells is the hallmark of the early asthmatic response, causing immediate bronchospasm. Antihistamines are generally not effective in asthma because other mediators also play significant roles.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "While leukotrienes and prostaglandins are also significant mediators, histamine is typically considered the primary and most rapid-acting bronchoconstrictor in the early phase.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_x438i840"
  },
  {
    "question": "Activation of which receptor directly mediates bronchoconstriction, mucus secretion, and airway edema in asthma?",
    "options": {
      "A": "Histamine H1",
      "B": "Beta-2 adrenergic",
      "C": "Cysteinyl Leukotriene 1",
      "D": "Muscarinic M3"
    },
    "correctAnswer": "C",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "Cysteinyl leukotrienes (LTC4, LTD4, LTE4) are potent lipid mediators released from mast cells, eosinophils, and macrophages. They bind to the Cysteinyl Leukotriene 1 (CysLT1) receptor, leading to sustained bronchoconstriction, increased mucus production, and airway edema. This makes the CysLT1 receptor a key target for antileukotriene medications like montelukast.",
    "highYieldPearl": "CysLT1 receptor antagonists block the effects of cysteinyl leukotrienes, which are 1000 times more potent than histamine in causing bronchoconstriction. They are particularly useful in aspirin-exacerbated respiratory disease (AERD) and exercise-induced bronchoconstriction.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "All options relate to airway function. H1 mediates histamine effects, M3 mediates cholinergic bronchoconstriction, and Beta-2 is for bronchodilation. The question specifically asks about the combined effects of bronchoconstriction, mucus, and edema mediated by a single receptor type, which strongly points to CysLT1.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_zwpeu5ll"
  },
  {
    "question": "A key structural change characterizing airway remodeling in chronic asthma is?",
    "options": {
      "A": "Alveolar destruction",
      "B": "Bronchial wall thinning",
      "C": "Subepithelial fibrosis",
      "D": "Cartilage calcification"
    },
    "correctAnswer": "C",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "Airway remodeling is a hallmark of chronic asthma, involving structural changes to the airway wall. Subepithelial fibrosis, characterized by deposition of collagen and other extracellular matrix proteins beneath the basement membrane, is a significant component that contributes to fixed airway obstruction and reduced reversibility. Other changes include smooth muscle hypertrophy/hyperplasia, goblet cell hyperplasia, and angiogenesis.",
    "highYieldPearl": "Airway remodeling contributes to the progressive and often irreversible airflow limitation seen in some patients with severe chronic asthma, making early and effective anti-inflammatory treatment crucial.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Alveolar destruction is characteristic of emphysema. Bronchial wall thinning is not a feature of remodeling; rather, thickening occurs. Cartilage calcification is not a primary feature of asthma remodeling.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_xdr71921"
  },
  {
    "question": "Which lymphocyte subset is central to orchestrating the allergic inflammatory response in asthma?",
    "options": {
      "A": "Th1 lymphocyte",
      "B": "Th2 lymphocyte",
      "C": "T regulatory lymphocyte",
      "D": "B lymphocyte"
    },
    "correctAnswer": "B",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "T helper 2 (Th2) lymphocytes are central to the pathogenesis of allergic asthma. Upon activation by allergen-presenting cells, Th2 cells release key cytokines (IL-4, IL-5, IL-13) that promote IgE production by B cells, eosinophil recruitment and activation, and mucus hypersecretion, respectively, driving the allergic inflammatory cascade.",
    "highYieldPearl": "The 'Th2 paradigm' explains the majority of allergic asthma. However, 'non-Th2' mechanisms involving Th17 cells and neutrophils are increasingly recognized in severe asthma phenotypes.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "While B lymphocytes produce IgE, they do so under the direction of Th2 cytokines. Th1 cells are involved in cell-mediated immunity and typically associated with protection against intracellular pathogens, not allergic asthma. Treg cells suppress immune responses.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_kkkwtton"
  },
  {
    "question": "Which Th2 cytokine primarily promotes B-cell IgE class switching and production?",
    "options": {
      "A": "Interleukin-1",
      "B": "Interleukin-4",
      "C": "Interleukin-6",
      "D": "Interleukin-17"
    },
    "correctAnswer": "B",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "Interleukin-4 (IL-4) is a critical Th2 cytokine that signals B cells to undergo class switching from IgM/IgD to IgE. This leads to the production of allergen-specific IgE antibodies, which then bind to mast cells and basophils, sensitizing them for future allergen encounters and triggering allergic reactions.",
    "highYieldPearl": "IL-4 is a key link between allergen exposure and the systemic IgE response. Omalizumab, an anti-IgE antibody, works by binding free IgE, preventing its binding to mast cells and thus reducing allergic reactions.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "IL-5 drives eosinophils, and IL-13 contributes to remodeling and mucus. IL-1 and IL-6 are pro-inflammatory but not specific for IgE class switching. IL-17 is associated with neutrophilic inflammation.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_pf67oy98"
  },
  {
    "question": "Bronchial hyperresponsiveness in asthma is primarily attributed to?",
    "options": {
      "A": "Reduced airway smooth muscle mass",
      "B": "Decreased vagal tone",
      "C": "Airway inflammation and remodeling",
      "D": "Increased surfactant production"
    },
    "correctAnswer": "C",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "Bronchial hyperresponsiveness (BHR) is a cardinal feature of asthma, characterized by an exaggerated bronchoconstrictor response to various stimuli. It is primarily driven by chronic airway inflammation, leading to changes in the airway smooth muscle (hypertrophy, hyperplasia), epithelial damage, neural dysfunction, and extracellular matrix deposition (remodeling). These factors collectively reduce the threshold for bronchoconstriction.",
    "highYieldPearl": "BHR is not just a symptom but a fundamental pathophysiological abnormality in asthma. It can be measured using challenge tests with methacholine or histamine.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "Reduced airway smooth muscle mass would lead to reduced bronchoconstriction, not hyperresponsiveness. Decreased vagal tone would reduce cholinergic bronchoconstriction. Increased surfactant production is irrelevant to BHR.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_48y1eq91"
  },
  {
    "question": "Damage to the airway epithelium in asthma contributes to increased susceptibility to?",
    "options": {
      "A": "Alveolar collapse",
      "B": "Bacterial translocation",
      "C": "Bronchial hyperresponsiveness",
      "D": "Pulmonary hypertension"
    },
    "correctAnswer": "C",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "Airway epithelial damage, a common finding in asthma, compromises the barrier function of the airway. This exposes subepithelial nerve endings to irritants and inflammatory mediators, leading to enhanced reflex bronchoconstriction and exaggerated responses to stimuli, thereby contributing significantly to bronchial hyperresponsiveness.",
    "highYieldPearl": "The airway epithelium is not just a passive barrier; it actively participates in the immune response by releasing cytokines and chemokines, further orchestrating inflammation in asthma.",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "While severe epithelial damage might theoretically increase infection risk (bacterial translocation), its primary and well-established role in asthma pathophysiology is in contributing to BHR. Alveolar collapse and pulmonary hypertension are not direct consequences of epithelial damage in asthma.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_akoitu8i"
  },
  {
    "question": "Which prostaglandin is a potent bronchoconstrictor and mast cell activator implicated in asthma?",
    "options": {
      "A": "Prostaglandin E2",
      "B": "Prostacyclin (PGI2)",
      "C": "Prostaglandin D2",
      "D": "Thromboxane A2"
    },
    "correctAnswer": "C",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "Prostaglandin D2 (PGD2) is a major cyclooxygenase product released from activated mast cells in allergic asthma. It is a potent bronchoconstrictor, increases vascular permeability, and has chemotactic effects on eosinophils and Th2 cells, contributing significantly to the asthmatic response.",
    "highYieldPearl": "Aspirin-exacerbated respiratory disease (AERD) involves an imbalance in arachidonic acid metabolism, with increased production of pro-inflammatory mediators like PGD2 and cysteinyl leukotrienes, and decreased production of anti-inflammatory PGE2.",
    "examStyle": "NEET-SS",
    "difficulty": "Hard",
    "trapAnalysis": "PGE2 is generally bronchodilatory and anti-inflammatory. PGI2 is also a vasodilator and bronchodilator. TXA2 is a potent vasoconstrictor and platelet aggregator but less central to asthma bronchoconstriction compared to PGD2 and leukotrienes.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_3972czkf"
  },
  {
    "question": "The late asthmatic response is predominantly characterized by the influx and activation of which inflammatory cells?",
    "options": {
      "A": "Neutrophils",
      "B": "Eosinophils",
      "C": "Macrophages",
      "D": "Basophils"
    },
    "correctAnswer": "B",
    "topic": "asthma_pathophys",
    "deepDiveExplanation": "The late asthmatic response, occurring 4-12 hours after allergen exposure, is characterized by a sustained inflammatory reaction. This phase is predominantly driven by the recruitment and activation of eosinophils, along with other cells like T lymphocytes and basophils, leading to persistent bronchoconstriction and airway hyperresponsiveness.",
    "highYieldPearl": "The late asthmatic response is more resistant to bronchodilators and is crucial for the development of chronic inflammation and airway remodeling, highlighting the importance of anti-inflammatory therapies (e.g., corticosteroids).",
    "examStyle": "NEET-SS",
    "difficulty": "Medium",
    "trapAnalysis": "While neutrophils can be present, especially in severe asthma, eosinophils are the hallmark cell of the classic late asthmatic response in allergic asthma. Macrophages are antigen-presenting cells and phagocytes, while basophils are less numerous than eosinophils in the late phase.",
    "isOneLiner": true,
    "id": "one_liner_one-liner|asthma_pathophys|Asthma - Pathophysiology|10_f6k6kemi"
  }
]